Open AccessThe Effect of Bisoprolol on Heart Failure Preserved Ejection Fraction / Hfpef Patient’s Quality Of Life
Author(s) -
Ayu Asri Devi Adityawati,
Anna Fuji Rahimah,
Mohammad Saifur Rohman,
Setyasih Anjarwani,
Djanggan Sargowo
Publication year - 2021
Publication title -
heart science journal
Language(s) - English
Resource type - Journals
eISSN - 2721-9984
pISSN - 2721-9976
DOI - 10.21776/ub.hsj.2021.002.04.6
Subject(s) - bisoprolol , medicine , heart failure , heart failure with preserved ejection fraction , ejection fraction , cardiology , quality of life (healthcare) , cohort , physical therapy , retrospective cohort study , nursing
Background: Global Public Health Burden of Heart Failure reported the growing prevalence of heart failure which is 64.3 million affected in 2020 worldwide with half of the case classified as Heart Failure Preserved Ejection Fraction (HFpEF). It is well known that someone who has been diagnosed with heart failure will have a poorer outcomes, one of them is QoL. Objective - Method: This study is a retrospective cohort following HFpEF patients who received bisoprolol and HFpEF patients who did not receive bisoprolol. The study participants were selected using purposive sampling method. Result: Our study found that from all HFpEF patients who received bisoprolol 102 patients had a good QoL and 2 patients had a poor QoL (p=0.000) according to Minnesota Living With Heart Failure Questionnaire (MLHFQ). The median physical score in the patient who did not receive bisoprolol was 10 while the median score of the Conclusion score, physical score, and emotional score.